trial · primary record
Suzetrigine
Diabetic Peripheral Neuropathic Pain
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 455 |
| Primary completion | 2027-01-25 |
| Primary endpoint | Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) |
| Registry ID | NCT06696443 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:06.583Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06696443
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Suzetrigine · approval
- Suzetrigine · compound